South Dakota statute
SDCL § 34-20B-20.3 — Medetomidine--Schedule III--Exceptions
Current through text effective June 30, 2026 (through the 2025 Regular Session)
Part of Chapter 20B: Drugs And Substances Control, South Dakota Codified Laws.
Full text of SDCL § 34-20B-20.3
Statutory text current through the text effective June 30, 2026 (through the 2025 Regular Session). This publication reproduces the official statutory text; it is not the official statutes of the State of South Dakota.
Any material, compound, mixture, or preparation that contains medetomidine is a Schedule III controlled drug or substance, except in the following cases:
(1) Dispensing, prescribing, or administering, to an animal, a drug that contains medetomidine and has been approved by the United States secretary of health and human services under 21 U.S.C. § 360b (January 1, 2026);
(2) Dispensing, prescribing, or administering medetomidine to an animal, as permissible under 21 U.S.C. § 360b(a)(4) (January 1, 2026);
(3) Manufacturing, distributing, or using medetomidine as an active pharmaceutical ingredient for manufacturing an animal drug:
(a) Approved under 21 U.S.C. § 360b (January 1, 2026); or
(b) Issued an investigational use exemption under 21 U.S.C. § 360b(j) (January 1, 2026);
(4) Manufacturing, distributing, or using a medetomidine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian; or
(5) Any other use approved or permissible under 21 U.S.C. §§ 301 to 399i, inclusive (January 1, 2026).
Official sources
Legal terms used in this section
This reference is informational and is not legal advice.